These findings suggest that, while BM-MSCsB-ALL retain their immunosuppressive effects on conventional T-cells, they do not compromise the activity of CD19-CAR T cells, suggesting that CD19-CAR T cells can effectively target and eliminate B-ALL cells even in the presence of the immunosuppressive bone marrow microenvironment [31]. This evidence concerns the gene CD19 and acute lymphoblastic leukemia.